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1. Introduction 
While using l-[3H]alkyl-2-linoleoyl-sn-glycerol as 
the labelled substrate for the synthesis of 1 -alkyl-2- 
acyl-sn-glycero-3-phosphocholines (alkylacyl-GPC) 
by the cholinephosphotransferase in rat brain 
microsomes, a significant labelling of 1-alkyl-Zacyl-sn- 
glycero-3-phosphoethanolamines (alkylacyl-GPE) 
was observed without any addition of CDP-ethanol- 
amine. A possible explanation is given in fig. 1, namely 
that the reverse reaction of rat brain ethanolamine- 
phosphotransferase may degrade endogenous 
microsomal ethanolamine phosphoglycerides. In the 
present paper we report the enhancement of the 
reverse reaction of both phosphotransferases by 
addition of CMP, a product of phosphotransferase 
reactions. 
2. Experimental 
Sprague-Dawley rats (6-8 weeks of age) were 
decapitated after ether anesthesia. The brains were 
immediately removed and homogenized in 0.32 M 
sucrose. The microsomal fraction was obtained as 
previously described [l] and then resuspended in 
ice-cold sucrose just before the incubation. 
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After saponification of rat fish (Chimera 
monstrosa) liver (Western Chemical Industries Ltd., 
Vancouver, Canada), 1-O-alkyl-sn-glycerols were 
separated by preparative thin-layer chromatography, 
and then reduced with tritium at New England 
Nuclear Laboratories, Boston, Mass. The product 
of the reaction consisted of a mixture of 1 -O- [3H]octa- 
decyl-snglycerol(63%) and l-O- [3H]hexadecyl-sn- 
glycerol (28%). The labelled alkylglycerols (1 .17 mg) 
had a specific radioactivity of 11 .O Ci/mmol. They 
were mixed with unlabelled alkylglycerols that were 
prepared from the same source and hydrogenated with 
Pt02 as catalyst. The [3H]alkylglycerols were acylated 
with linoleoyl chloride (Sigma Chemical Co., St. 
Louis, MO.) in the presence of pyridine as described 
by Chacko and Hanahan [2]. The 1-0-[3H]alkyl-2,3- 
dilinoleoyl-sn-glycerols obtained as a product of this 
reaction were isolated and purified with column 
chromatography on Unisil silicic acid (Clarkson 
Chemical Co., Williamsport, Pa.), according to Carrol 
and Serdarevich [3]. This product was incubated with 
pancreatblipase (Steapsin, Nutritional Biochemical 
Corp., Cleveland, Ohio) as described by Radominska- 
Pyrek and Horrocks [4]. The l-O-[3H]alkyl-2-linoleoyl- 
sn-glycerols were then purified by column [5] and 
thin-layer [4] chromatography. The amount of labelled 
alkylacylglycerols was measured from the content of 
the ester bonds by the method of Stern and Shapiro 
[6] using methyl palmitate as a standard. We obtained 
240 pmol of 1 -O- [ 3H]alkyl-2-linoleoyl-sn-glycerols with 
a specific radioactivity of 0.5 17 Ci/mol. Just before 
use, an 8 mM alkylacylglycerol emulsion was prepared 
by sonication [4] in a convenient volume of 50 mM 
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Tris-HCl, pH 7.6, containing 0.5% Tween 20. Incuba- 
tions were carried out as reported in tables 1 and 2. 
The reaction was stopped by adding 4.5 ml of 
chloroform-methanol 2: 1 (v/v) and the lipids were 
extracted [7]. Protein contents were determined 
according to Lowry et al. [8]. The isolation of lipids 
was carried out by thin-layer chromatography as 
described previously [4] except chloroform- 
methanol-H,O, 65:25:4 (v/v/v) was used as the 
solvent for the first dimension. The spots corre- 
sponding to acid-stable ethanolamine and choline 
phosphoglycerides were scraped directly into counting 
vials. Distilled water (3 ml) and 10 ml Instagel 
(Packard, Downers Grove, Ill.) were added and the 
mixture was counted [9]. 
3. Results 
Increasing amounts of [3H]alkylacylglycerols 
were incorporated into choline phosphoglyceride 
and ethanolamine phosphoglyceride with increasing 
time (table 1). Although no CDP-ethanolamine was 
added, the proportion of radioactivity in the ethanol- 
amine phosphoglyceride was about 3% of the total 
incorporated. The presence of absorbed CDP-ethanol- 
amine on the microsomes is unlikely because 3H in 
the ethanolamine phosphoglyceride was not detected 
at 2 min, but then labelled ethanolamine phospho- 
Table 1 
Incorporation of [3H]alkylacylglycerols into the alkylacyl-GPC 
and alkylacylGPE of rat brain microsomes as a function of 
time in the presence of CDP-choline 
Incubation 
(min) 
2 
4 
8 
15 
30 
Incorporation (nmol/mg protein) into 
Alkylacyl-GPC Alkylacyl-GPE 
2.10 N.D. 
5.22 0.17 
12.0 0.31 
15.9 0.43 
29.8 0.94 
Incubation mixture: Tris-HCI, pH 8.0 (58 mM); MgCI, 
(20 mM); dithiothreitol(O.08 mM); CDP-choline (1.066 mM); 
l-[ 3H]alkyl-2-linoleoyi-sn-glycerols (1.33 mM); Tween 20 
(0.008%); brain microsomal protein (0.9 mg). Final volume: 
0.3 ml. Temperature: 39°C. 
N.D., not detected. 
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[3H]slXylaeylgLycerol + CDP-choline * [JHlalkylacyl-GPC + CMP (1) 
cm + endogenous EPG + cm-ethanolamine * diglyceridel (2) 
CDP-ethanolanine 1 [JH]altylacylglyceroI + [%i]alXylacyl-GPE . CHP (3) 
CMP f emiogenous CPG + CDP-choline * diglyceride (4) 
Fig.l. Enzymic steps for production of [ 3H]alkylacyl-GPE 
from [ 3H]alkylacylg,lycerol and CDP-choline (reactions l-3), 
and for production of [ ‘HJalkylacyl-GPC from [ ‘H]alkyl- 
acylglycerol and CDP-ethanolamine (reactions 3,4 and 1). 
Reactions 1 and 4 are catalyzed by choline phosphotrans- 
ferase. Abbreviations are: CPG, choline phosphoglyceride 
and EPG, ethanolamine phosphoglyceride. 
glyceride increased with time. If the labelled ethanol- 
amine phosphoglycerides were due to the liberation of 
CDP-ethanolamine by CMP (fig.l), then the addition 
of CMP to the incubation medium should increase the 
proportion of radioactivity in the ethanolamine 
phosphoglyceride. In the experiment reported in 
table 2, this proportion was increased from 1.5 to 2.1%. 
Nearly 9% of the radioactivity was incorporated into 
choline phosphoglyceride when CDP-ethanolamine 
was the added nucleotide (table 2). This proportion 
was increased to 3 1% by inclusion of CMP in the 
incubation medium. 
4. Discussion 
Brain choline and ethanolamine phosphotransferases 
seem to be reversible as judged by results of CMP 
addition (table 2). Reversibility of both phospho- 
transferases has been described in other tissues [lo-l 51. 
Although the brain enzymes are quite active 
[4,7,16-221, they were thought to be irreversible 
because the specific radioactivities of the phospho- 
glycerides do not equilibrate with specific radioactivities 
of the CDP-choline or CDP-ethanolamine in vivo 
[23,24]. A competitive inhibition by CMP of the 
choline phosphotransferase from chicken brain has 
been described [ 181. 
The incorporation of labelled alkyl groups into 
choline phosphoglyceride in the presence of CDP- 
ethanolamine and into ethanolamine phospho- 
glyceride in the presence of CDP-choline can be 
explained by the reactions in fig.1. Snyder et al. 
[25] reported similar results after incubation of 
labelled alkylacylglycerophosphates with micro- 
somes from preputial gland tumors. Similar reverse 
Volume 80, number 1 FEBS LETTERS 
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The effect of CMP addition on the incorporation of [ 3H]alkylacylglycerol into 
alkylacyl-GPC and alkylacyl-GPE of rat brain microsomes 
Addition Incorporation (nmol/mg protein/h) into 
Alkylacyl-GPC Alkylacyl-GPE 
CDP-choline 43.4 0.69 
CDP-choline + CMP 43.1 0.95 
CDP-ethanolamine 3.48 36.3 
CDP-ethanolamine + CMP 8.21 18.5 
Incubation mixture: Tris-HCl, pH 8.0 (58.0 mM); MgCl, (20 mM) or MnClz 
(10 mM); dithiothreitol (0.08 mM); 1-[3H]aJkyl-2-linoleoyl-sn-glycerol (1.07 mM); 
Tween 20 (0.008%); brain microsomal protein (0.8 mg). Final volume: 0.3 ml. 
Temperature: 39°C. Incubation time: 30 min. CDP-choline, CDP-ethanolamine or 
CMP were added (1 mM) as specified. MgCl, or MnCl, were used with CDP- 
choline and CDP-ethanolamine, respectively. 
reactions may explain part of the labelling of 
plasmalogens in previous experiments carried out 
with alkylacylglycerols and labelled nucleotides 
[4,20-221 and may account for the phospho- 
ethanolamine exchange proposed by Wykle and 
Lockmiller [26]. 
Diglycerides are released from brain phospho- 
glycerides during ischemic and electroconvulsive 
states [27,28] and can be further degraded by a 
lipase [29]. The release could be mediated by a 
phospholipase C [30,31] with release of the 
phosphorylated base or by reversal of a phospho- 
transferase with release of the choline phospho- 
glyceride nucleotide. The latter may be responsible 
for the effects found in our experiments. 
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